• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Gilead, Arcus hope to ease TIGIT anxieties with latest trial data tease

cafead

Administrator
Staff member
  • cafead   Nov 28, 2022 at 07:53: PM
via The jury remains out on the prospects of anti-TIGIT checkpoint inhibitors but Gilead and Arcus Biosciences are hoping to ease concerns that the modality is a bust, teasing new phase 2 data.

article source
 

<